Having trouble viewing this email? View in your browser.
ESCMID Logo

6 March 2018
WEEKLY NEWS

Dear colleagues,

At its office in Basel ESCMID is seeking a qualified Science Manager (100%) who supports the ESCMID Executive Committee and the congress director in dealing with the society’s scientific matters.  

ESCMID supports members who want to attend the International Immunocompromised Host Society (ICHS) meeting in Athens with an attendance grant covering the registration fee. All inquiries should be addressed to William R. Kirkpatrick.

EUCIC is organising a local module in Portugal on 7 April 2018. You may already register for the workshop Improving antibiotic prescription and infection control in the Emergency Room.

ESCMID’s published its new Code of Conduct, which outlines how the society maintains its high standard of ethical conduct and how it complies with laws, binding standards and internal policies.

Your ESCMID communications editors

 

ESCMID Observership: applications being accepted from tomorrow!

As of tomorrow, 7 March, at noon CET, you can click on this link to apply for one of the 50 funded observerships available. The deadline is 18 March so make sure you get your application to us before then. Donīt forget to pay attention to the updated criteria and ensure you have all the necessary documents to send with your application. You may also apply for unfunded observerships via this link.

Any questions, please contact observerships@escmid.org. The next call for funded observerships will be announced in the summer.

› Read more
 

ESCMID updates guidance on prevention of C. difficile infection

Clostridium difficile infection (CDI) is the most important infective cause of healthcare-associated diarrhoea in high income countries and one of the most important healthcare-associated pathogens. Given the ongoing significance of CDI in Europe, the ESCMID study group for C. difficile (ESGCD) updated its guideline, reviewing the literature on interventions to control CDI in adult populations in acute health care settings and deriving specific infection control recommendations. The guidance provides 36 statements on strategies to prevent CDI in acute care settings, including 18 strong recommendations. Strong recommendations were made for a two-stage test to diagnose CDI (focus on prevention of transmission), performance of surveillance with timely feedback, not to screen healthcare workers, the use of personal protective equipment in outbreak settings, implementation of contact precautions, introduction of daily environmental sporicidal disinfection and terminal disinfection of rooms of patients with CDI in outbreak settings, antibiotic stewardship interventions (including restriction of antibiotic agents/classes and reducing duration of antibiotic exposure), as well as for education of healthcare workers, patients and visitors on prevention measures. The highest quality of evidence grading was identified for antibiotic stewardship interventions.

› Read more
 

Save the date: TAE Day at ECCMID is on 21 April

The TAE Day returns to ECCMID on Saturday 21 April 2018. The session, which starts at 13:15 in Hall Y, is made up of round table sessions held with recognized experts in CM and ID, who lead discussions about career development and share their own work-life experiences. The TAE awards for Training Achievement will also be presented during this event and the Young Investigator awardees will share their career experience too.  For more information on the success if last year`s event, click here. Mark the date in your diary and look out for information on how to register coming soon.

› Read more
 

ESCMID to spend EUR 300,000 on its 2018 research grants

ESCMID has received 162 research grant proposals received for research projects dealing with bacterial infections, which received a total of 488 reviews. The ESCMID Executive Committee selected 15 grantees from nine different countries, which corresponds to a very competitive acceptance rate of 9.2%. The society spent EUR 300,000 on the research funding. Congratulations to the grantees. Applications for 2019 research grants will be accepted from July until October 2018. Only projects dealing with fungal/viral/parasitic infections and diseases (incl. diagnostics, pathogenesis, antifungal/antiviral/antiparasitic susceptibility & resistance, stewardship, vaccines) will be accepted.

› Read more
 

ESCMID/ASM AMR conference registration, abstract submission open

The ESCMID/ASM conference on drug development to meet the challenge of antimicrobial resistance (AMR) will take place in Lisbon, Portugal, from 4 – 7 September 2018. The registration and the submission of abstracts on original data for poster and platform presentations are open now. The conference focusses on the development of new antimicrobial agents to tackle AMR, which remains a pressing public health problem. The multidisciplinary meeting involves basic scientists, clinical academics, regulatory bodies, funding bodies and the pharmaceutical industry. Its scope stretches from chemistry to clinical development, from neonates to adults, from bacteria to fungi – all with a global perspective. The meeting is practical, interactive with plenty of time for networking. ESCMID will support young investigators and researchers from low and middle-income countries.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.